Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial.
暂无分享，去创建一个
S. Culine | G. Gravis | F. Joly | P. Barthélémy | K. Fizazi | P. Beuzeboc | A. Fléchon | E. Bompas | R. Ratta | M. Gross-goupil | I. Borget | J. Berdah | Y. Tazi | G. Baciarello | M. Deblock | G. Martineau | R. Delva | C. Greilsamer | T. N. T. Hon | C. Cheneau | A. Maillard | A. Flechon | M. Gross‐Goupil | M. Gross-Goupil